Close Menu

A Slippery Slope?

The Los Angeles Times' Booster Shots blog examines the National Collegiate Athletic Association's plan to "screen close to 167,000 college athletes for 'sickle cell trait,'" in light of a warning from two experts at the National Human Genome Research Institute that the program is "full of potential pitfalls." According to the LA Times, the NCAA program "aims to identify carriers of a single sickle-cell gene," as these individuals "have unusual vulnerabilitie

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.